HAX

HAX is a global venture capital-backed program dedicated to accelerating startups with a hardware element. Operating across San Francisco and Shenzhen, HAX focuses on rapid prototyping and iteration, helping teams refine their products, business plans, and launch strategies. The program culminates in market readiness support, including introductions to corporates, investors, partners, and press, as well as securing funding and gaining traction.

Andrew Gollach

Principal

Ji Ke

Partner, Program Director and CTO

Past deals in Medical Devices

Vision IV

Seed Round in 2025
Vision IV develops, produces diamond integrated anvil to evaluate, change and synthesize the properties of susbstances under high pressure.

InnSight Technology

Seed Round in 2025
InnSight Technology is a biotechnology company focused on advancing the diagnostics and evaluation of eye diseases. The company specializes in developing innovative ophthalmic devices, including a novel, hand-held biosensor designed for the detection of anterior ophthalmic injuries. Additionally, InnSight Technology works on the development of nanotechnology-based medical devices aimed at addressing various clinical needs in ophthalmology. By providing these advanced tools, the company enables clinicians to enhance ocular care and improve patient outcomes in eye health.

Sharper Sense

Seed Round in 2025
Sharper Sense develops wearable neurotechnology to enhance vision, hearing, and touch. The company focuses on a neuromodulation patch that delivers non-invasive electrical stimulation to improve sensory acuity and perception, with potential applications for processing disorders and sensory loss, and to boost performance, enabling clearer, more accurate perceptions for improved task precision and safety.

Serene Sleep

Seed Round in 2024
Serene Sleep is a medical technology company that focuses on improving sleep quality by addressing snoring and sleep apnea. It develops and offers a non-invasive, targeted treatment procedure using palatal implants, designed to reduce disruptive snoring and enhance overall sleep for both the individual and their partner.

Samphire Neuroscience

Seed Round in 2024
Founded in 2021, Samphire Neuroscience specializes in developing neurotechnological solutions for women's health. Its flagship product is a non-invasive headband device that uses electrical neuromodulation to alleviate symptoms such as pain, fatigue, and mood changes associated with menstrual cycles.

Macheon

Seed Round in 2024
Macheon AI is a robotics company specializing in the manufacture of surgical robots for head and neck procedures. These robots incorporate real-time, AI-driven decision support, aiming to enhance surgical precision, safety, and efficiency.

OLI

Seed Round in 2024
Medical Devices, Kidney Disease, Wearables, Medtech, Hardtech

Bloomlife

Series B in 2024
Bloomlife is a pioneering company in maternal health, leveraging connected devices and cloud-based data analytics to enhance access to care for expectant mothers. Its innovative solution enables obstetricians to more efficiently screen and manage pregnancy complications, empowering women and reducing geographical barriers.

Medical Devices Corner

Pre Seed Round in 2024
Medical Devices Corner is a company focused on developing innovative medical devices aimed at enhancing cancer diagnosis and treatment. It specializes in creating advanced robotic systems designed to improve the efficacy and precision of minimally invasive surgical procedures. By concentrating on device technology, Medical Devices Corner supports healthcare professionals in performing biopsies and ablative procedures with greater accuracy and less patient trauma. The company's commitment to advancing medical technology positions it as a significant contributor to the healthcare industry, particularly in the realm of surgical advancements.

ZiO Health

Convertible Note in 2024
ZiO Health is a biotechnology company that develops pocket-sized devices featuring proprietary biosensor technology and machine learning algorithms. These devices enable real-time laboratory testing at the point-of-care, enhancing patient care by combining immediate results with individual patient profiles.

Zhenshi Medical

Convertible Note in 2024
Zhenshi Medical is a medical device company that specializes in lung puncture medical robots for diagnosing and treating lung cancer.

DeepSpin

Convertible Note in 2024
DeepSpin GmbH, founded in 2019 and based in Berlin, Germany, specializes in the development of an innovative artificial intelligence-powered magnetic resonance imaging (MRI) system. The company's technology aims to significantly reduce the cost, size, and weight of traditional MRI machines, thereby enhancing accessibility to medical imaging for patients worldwide. By utilizing generative topological design for its hardware and deep learning techniques for image processing, DeepSpin's MRI system seeks to make advanced medical imaging available in a variety of previously underserved healthcare settings. This approach not only aims to improve patient care but also to democratize access to essential medical diagnostics globally.

kegg

Series A in 2024
kegg is a fertility health tracking device from a San Francisco based company founded in 2017 that combines fertility tracking with pelvic floor exercises. The device analyzes changes in cervical fluids to detect the fertile window and ovulation up to seven days in advance, providing users with information to guide conception decisions. By collecting data from cervical fluids, it aims to support women’s health through improved diagnosis, monitoring, and planning related to fertility.

FeetMe

Series B in 2024
FeetMe is a digital health company that develops a platform and connected footwear insoles for gait and movement analysis in-clinic and real-world settings. The technology combines pressure sensors, motion data, and learning algorithms to provide real-time gait and posture insights and digital biomarkers to support clinical research and improve care for patients with movement disorders and mobility constraints. These insights enable clinicians to monitor disease progression, tailor treatments, and optimize medication use by assessing mobility capacity and tracking changes over time.

Lief Therapeutics

Seed Round in 2024
Lief Therapeutics is a medical device company based in San Francisco, California, focused on enhancing at-home care for individuals dealing with post-traumatic stress disorder, depression, and anxiety. The company has developed a discreet bio-sensing patch that accurately measures heart rate and breath, allowing users to manage their natural stress response through vibratory biofeedback exercises. This wearable device helps users monitor their behaviors, emotions, and thoughts in real-time, fostering mindfulness and control throughout the day. Additionally, it supports clinicians by tracking patient progress, facilitating in-session training, and scheduling psychological assessments. Lief Therapeutics also offers the Lief Health Score application, which records thoughts, emotions, and sensations, enabling users to track daily progress and engage in tailored exercises. Founded in 2014, the company sells its products online, aiming to empower individuals in their mental health journeys.

Strados Labs

Convertible Note in 2024
Strados Labs, LLC is a medical technology company based in Philadelphia, Pennsylvania, specializing in respiratory health management through innovative sensor-based solutions. Founded in 2016, the company has developed a wearable device that provides real-time insights into breathing patterns, sounds, and speed. This device is equipped with clinical-grade biosensors and smart software, allowing for continuous monitoring of respiratory conditions such as asthma and chronic obstructive pulmonary disease. By connecting to a mobile application, Strados enables users and healthcare providers to access and analyze respiratory data, facilitating informed health decisions and remote patient monitoring.

Samphire Neuroscience

Pre Seed Round in 2024
Founded in 2021, Samphire Neuroscience specializes in developing neurotechnological solutions for women's health. Its flagship product is a non-invasive headband device that uses electrical neuromodulation to alleviate symptoms such as pain, fatigue, and mood changes associated with menstrual cycles.

XN Health

Convertible Note in 2024
XN Health is a medical device company founded in 2021 and based in Texas, USA. The company focuses on developing innovative healthcare solutions to assist mechanically ventilated patients in weaning off ventilators more efficiently. Its primary product utilizes phrenic nerve stimulation to induce diaphragm contractions, thereby mitigating the risks of diaphragm dysfunction associated with prolonged mechanical ventilation. By enhancing the weaning process, XN Health aims to improve patient outcomes and facilitate recovery in critical care settings.

3DK Tech

Seed Round in 2023
3DK Tech, based at HAX, specializes in proprietary metal printing technology for aviation maintenance, repair, and overhaul (MRO) services.

Lura Health

Seed Round in 2023
Lura Health develops a non-invasive continuous health monitoring platform that uses saliva as a diagnostic fluid. The company integrates micro-sensors into orthodontic devices such as retainers, aligners, and brackets to continuously measure saliva analytes and securely transmit data to a smartphone app, enabling users to monitor oral health metrics and potentially support broader chronic disease management. Target markets include heart disease, chronic kidney disease, diabetes, and tooth decay. Founded in 2017, the company is based in Cambridge, Massachusetts.

OLI

Seed Round in 2023
Medical Devices, Kidney Disease, Wearables, Medtech, Hardtech

LightHearted AI

Seed Round in 2023
LightHearted AI is a company that specializes in developing an AI-driven remote cardiovascular diagnostics tool aimed at improving the detection of heart conditions. This medical device is designed to deliver rapid, precise, and cost-effective assessments, addressing the critical need to prevent heart-related deaths. By leveraging advanced technology, LightHearted AI enhances the capabilities of healthcare professionals, allowing for faster and more accurate diagnostic procedures compared to traditional methods. The company's innovation seeks to transform cardiac care, ultimately contributing to better treatment outcomes for patients.

Feel Therapeutics

Convertible Note in 2023
Feel Therapeutics is a digital health company specializing in precision medicine for mental health. It develops physiological and digital biomarkers using advanced computer science methods, leveraging wearable devices to collect and analyze biometric data.

Artyc

Series A in 2023
Artyc specializes in providing sustainable cold shipping solutions tailored for the biotech, pharmaceutical, and medical sectors. The company manufactures refrigerant-free, reusable, active cooling containers that enhance the efficiency of cold logistics. By focusing on decarbonizing the cold chain, Artyc aims to create a more sustainable logistics industry. Their innovative containers not only help businesses reduce shipping costs but also enable effective temperature monitoring, ensuring the safe transport of sensitive goods.

Samphire Neuroscience

Convertible Note in 2023
Founded in 2021, Samphire Neuroscience specializes in developing neurotechnological solutions for women's health. Its flagship product is a non-invasive headband device that uses electrical neuromodulation to alleviate symptoms such as pain, fatigue, and mood changes associated with menstrual cycles.

Vivo Care

Series B in 2023
Vivo Care develops a remote care software platform that supports remote patient monitoring and chronic disease management. The platform integrates patient-centered monitoring technology, connected devices, and clinical support to help healthcare providers deliver equitable care across diverse patient populations, improve patient outcomes, and modernize the patient experience. It enables scalable deployment of RPM and chronic care management programs, enhances patient engagement, and aims to deliver compliant and reliable reimbursement revenue for providers, supporting both clinical and financial results.

Medical Devices Corner

Convertible Note in 2023
Medical Devices Corner is a company focused on developing innovative medical devices aimed at enhancing cancer diagnosis and treatment. It specializes in creating advanced robotic systems designed to improve the efficacy and precision of minimally invasive surgical procedures. By concentrating on device technology, Medical Devices Corner supports healthcare professionals in performing biopsies and ablative procedures with greater accuracy and less patient trauma. The company's commitment to advancing medical technology positions it as a significant contributor to the healthcare industry, particularly in the realm of surgical advancements.

DIA

Grant in 2023
Dia has invented an electrochemical sensor that can measure a wide variety of chemical biomarkers non-invasively in saliva or sweat. The data is sent via Bluetooth to an app on the user’s smartphone and analyzed in real-time. From the app, it can be securely sent to a third party. To date, we have measured hormones, electrolytes, neurotransmitters and metabolites. At DIA, we let the biology dictate which analyte we put on which platform – our wearable arm sleeve for sweat or our table-top device for saliva – because some biomarkers, such as cortisol fluctuate throughout the day and need to be monitored through a wearable sensor, while others, such as creatinine are more suitable to a daily saliva test.

Japet Medical

Convertible Note in 2023
Japet Medical is a French biomedical company specializing in the development of robotic medical devices. Their focus lies in creating efficient and user-friendly solutions designed to enhance treatment quality and improve patients' lives.

Lief Therapeutics

Convertible Note in 2022
Lief Therapeutics is a medical device company based in San Francisco, California, focused on enhancing at-home care for individuals dealing with post-traumatic stress disorder, depression, and anxiety. The company has developed a discreet bio-sensing patch that accurately measures heart rate and breath, allowing users to manage their natural stress response through vibratory biofeedback exercises. This wearable device helps users monitor their behaviors, emotions, and thoughts in real-time, fostering mindfulness and control throughout the day. Additionally, it supports clinicians by tracking patient progress, facilitating in-session training, and scheduling psychological assessments. Lief Therapeutics also offers the Lief Health Score application, which records thoughts, emotions, and sensations, enabling users to track daily progress and engage in tailored exercises. Founded in 2014, the company sells its products online, aiming to empower individuals in their mental health journeys.

Samphire Neuroscience

Seed Round in 2022
Founded in 2021, Samphire Neuroscience specializes in developing neurotechnological solutions for women's health. Its flagship product is a non-invasive headband device that uses electrical neuromodulation to alleviate symptoms such as pain, fatigue, and mood changes associated with menstrual cycles.

Kinexcs

Convertible Note in 2022
Kinexcs is an AI-driven health technology company focused on improving mobility and quality of life for individuals with musculoskeletal conditions. It offers a digital therapy solution comprising KIMIA, the world's first continuous knee health monitor, and an AI-based digital therapist for convenient and cost-effective access to therapy.

PONS

Pre Seed Round in 2022
PONS is a company specializing in the development of artificial intelligence to enhance ultrasound imaging, particularly for brain diagnostics. Utilizing machine learning algorithms, PONS transforms traditional ultrasound systems into smart, AI-driven diagnostic tools that improve scan resolution, tissue contrast, and noise reduction. This innovation aims to provide expert-level insights without the need for costly new hardware. The company's primary objective is to create a wearable ultrasound device to assist first responders and ambulance doctors with pre-diagnostics in challenging circumstances, facilitating early disease detection and preventive screening. By focusing on important anatomical features in ultrasound scans, PONS seeks to advance the capabilities of ultrasound technology in neurosurgery and related fields.

FluidAI

Seed Round in 2022
FluidAI is a medical technology company focused on post-operative care, combining artificial intelligence with in-body data to improve patient monitoring. The company develops a smart catheter system that enables proactive post-operative care by detecting complications at onset and delivering critical health data to healthcare providers ahead of time.

Artyc

Seed Round in 2022
Artyc specializes in providing sustainable cold shipping solutions tailored for the biotech, pharmaceutical, and medical sectors. The company manufactures refrigerant-free, reusable, active cooling containers that enhance the efficiency of cold logistics. By focusing on decarbonizing the cold chain, Artyc aims to create a more sustainable logistics industry. Their innovative containers not only help businesses reduce shipping costs but also enable effective temperature monitoring, ensuring the safe transport of sensitive goods.

Artyc

Convertible Note in 2022
Artyc specializes in providing sustainable cold shipping solutions tailored for the biotech, pharmaceutical, and medical sectors. The company manufactures refrigerant-free, reusable, active cooling containers that enhance the efficiency of cold logistics. By focusing on decarbonizing the cold chain, Artyc aims to create a more sustainable logistics industry. Their innovative containers not only help businesses reduce shipping costs but also enable effective temperature monitoring, ensuring the safe transport of sensitive goods.

Portable Diagnostic Systems

Seed Round in 2022
Founded in August 2019, Portable Diagnostic Systems develops a microfluidics-based drug testing platform for law enforcement. This platform uses salivary diagnostics, antibody engineering, and micro-fluidics to accurately screen drugs from a small saliva sample collected at roadside stops, aiming to reduce false positives and enhance traffic stop efficiency.

Zennea Technologies

Convertible Note in 2022
Zennea Technologies is a medical device company based in Surrey, Canada, specializing in the development of therapeutic wearables aimed at reducing snoring and improving overall health through enhanced sleep quality. The company's flagship product, ZENS, is a comfortable and discreet sleep wearable that targets the root cause of snoring, thereby assisting individuals with chronic snoring and mild obstructive sleep apnea. Zennea conducts clinical trials to validate the efficacy of its device, which not only helps reduce snoring but also tracks sleep quality, providing valuable insights for users to make informed decisions about their health and sleep habits.

FeetMe

Convertible Note in 2022
FeetMe is a digital health company that develops a platform and connected footwear insoles for gait and movement analysis in-clinic and real-world settings. The technology combines pressure sensors, motion data, and learning algorithms to provide real-time gait and posture insights and digital biomarkers to support clinical research and improve care for patients with movement disorders and mobility constraints. These insights enable clinicians to monitor disease progression, tailor treatments, and optimize medication use by assessing mobility capacity and tracking changes over time.

Harae Dx

Convertible Note in 2022
Harae Dx Corp. is a medical diagnostics company that has created a compact and portable multi-cancer detection system. This innovative platform enables automated cancer diagnostics by detecting cancer biomarkers directly, eliminating the need to send specimens to third-party laboratories. By reducing the potential for human processing errors and improving turnaround times for results, Harae Dx's technology allows healthcare professionals to identify and treat cancer at an early stage more effectively and affordably.

Leadoptik

Angel Round in 2022
Leadoptik specializes in developing miniature imaging platforms that enhance minimally invasive interventions. Its technology offers high-resolution imaging and real-time 3D navigation capabilities, aiding surgeons in detecting early-stage cancers.

Hydrostasis

Convertible Note in 2021
Hydrostasis develops a hydration monitor system for athletes to reach and maintain peak performance. The wearable sensors measure each athlete's optimal hydration range based on body composition and provide preventive notifications before dehydration symptoms affect performance. Based in San Diego, California, Hydrostasis collaborates with device manufacturers in both consumer and clinical applications to enable hydration monitoring capabilities. The company delivers personalized information with device-agnostic and clinical-grade accuracy and uses cloud-based data storage to deliver real-time, actionable hydration insights, enabling athletes to track their hydration ranges and sustain optimal performance.

Samphire Neuroscience

Seed Round in 2021
Founded in 2021, Samphire Neuroscience specializes in developing neurotechnological solutions for women's health. Its flagship product is a non-invasive headband device that uses electrical neuromodulation to alleviate symptoms such as pain, fatigue, and mood changes associated with menstrual cycles.

Criam

Seed Round in 2021
Criam is a Portuguese biotechnology company based in Braga that develops portable diagnostic technology for blood typing and infectious disease detection. Its stand-alone platform does not require electricity or laboratory infrastructure, enabling rapid testing at the point of care. A single reader can perform multiple tests using cartridges and computer vision algorithms to detect a broad range of diseases, including HIV, with real-time data to support clinical decisions. The system leverages lab-on-a-chip concepts and biomarker detection algorithms to deliver fast, user-friendly, and cost-effective diagnostics in diverse settings, including remote environments and emergency care.

XXICO

Seed Round in 2021
XXICO is a platform consisting of devices and software that enable remote health monitoring.

Harae Dx

Seed Round in 2021
Harae Dx Corp. is a medical diagnostics company that has created a compact and portable multi-cancer detection system. This innovative platform enables automated cancer diagnostics by detecting cancer biomarkers directly, eliminating the need to send specimens to third-party laboratories. By reducing the potential for human processing errors and improving turnaround times for results, Harae Dx's technology allows healthcare professionals to identify and treat cancer at an early stage more effectively and affordably.

DeepSpin

Convertible Note in 2021
DeepSpin GmbH, founded in 2019 and based in Berlin, Germany, specializes in the development of an innovative artificial intelligence-powered magnetic resonance imaging (MRI) system. The company's technology aims to significantly reduce the cost, size, and weight of traditional MRI machines, thereby enhancing accessibility to medical imaging for patients worldwide. By utilizing generative topological design for its hardware and deep learning techniques for image processing, DeepSpin's MRI system seeks to make advanced medical imaging available in a variety of previously underserved healthcare settings. This approach not only aims to improve patient care but also to democratize access to essential medical diagnostics globally.

Medical Devices Corner

Seed Round in 2021
Medical Devices Corner is a company focused on developing innovative medical devices aimed at enhancing cancer diagnosis and treatment. It specializes in creating advanced robotic systems designed to improve the efficacy and precision of minimally invasive surgical procedures. By concentrating on device technology, Medical Devices Corner supports healthcare professionals in performing biopsies and ablative procedures with greater accuracy and less patient trauma. The company's commitment to advancing medical technology positions it as a significant contributor to the healthcare industry, particularly in the realm of surgical advancements.

Leadoptik

Seed Round in 2020
Leadoptik specializes in developing miniature imaging platforms that enhance minimally invasive interventions. Its technology offers high-resolution imaging and real-time 3D navigation capabilities, aiding surgeons in detecting early-stage cancers.

kegg

Convertible Note in 2020
kegg is a fertility health tracking device from a San Francisco based company founded in 2017 that combines fertility tracking with pelvic floor exercises. The device analyzes changes in cervical fluids to detect the fertile window and ovulation up to seven days in advance, providing users with information to guide conception decisions. By collecting data from cervical fluids, it aims to support women’s health through improved diagnosis, monitoring, and planning related to fertility.

RxAll

Convertible Note in 2020
RxAll, Inc. is a technology company that specializes in developing an artificial intelligence-driven platform for the authentication and distribution of pharmaceuticals, primarily in Africa. Founded in 2015 and headquartered in New Haven, Connecticut, the company utilizes a deep learning hyperspectral Internet of Things (IoT) platform that incorporates a molecular sensor device and a cloud database of spectral signatures. This innovative approach allows for non-destructive authentication of medications, including prescription and over-the-counter drugs, before they are dispensed. RxAll aims to combat the issue of counterfeit drugs by providing real-time information to pharmaceutical manufacturers about the authenticity of their products. Additionally, the platform facilitates access to authenticated medicines for patients and pharmacies, while also offering tele-pharmacy primary care services.

Strados Labs

Convertible Note in 2020
Strados Labs, LLC is a medical technology company based in Philadelphia, Pennsylvania, specializing in respiratory health management through innovative sensor-based solutions. Founded in 2016, the company has developed a wearable device that provides real-time insights into breathing patterns, sounds, and speed. This device is equipped with clinical-grade biosensors and smart software, allowing for continuous monitoring of respiratory conditions such as asthma and chronic obstructive pulmonary disease. By connecting to a mobile application, Strados enables users and healthcare providers to access and analyze respiratory data, facilitating informed health decisions and remote patient monitoring.

Sepsitron

Pre Seed Round in 2020
Sepsitron is a medical diagnostic technology company focused on the early detection of blood infections. Its innovative approach utilizes a combination of unique biomarkers, microfluidics, and advanced electronics to enable rapid identification of multiple pathogens—including viral, bacterial, parasitic, and fungal—using a single test. The device is designed for point-of-care applications, offering a significant advantage by delivering results 50 times faster and at one-tenth the cost of conventional methods. Importantly, Sepsitron's tests do not require any sample pre-processing and can analyze whole blood samples, allowing healthcare professionals to diagnose and initiate treatment for infections more efficiently.

DeepSpin

Seed Round in 2020
DeepSpin GmbH, founded in 2019 and based in Berlin, Germany, specializes in the development of an innovative artificial intelligence-powered magnetic resonance imaging (MRI) system. The company's technology aims to significantly reduce the cost, size, and weight of traditional MRI machines, thereby enhancing accessibility to medical imaging for patients worldwide. By utilizing generative topological design for its hardware and deep learning techniques for image processing, DeepSpin's MRI system seeks to make advanced medical imaging available in a variety of previously underserved healthcare settings. This approach not only aims to improve patient care but also to democratize access to essential medical diagnostics globally.

Lura Health

Convertible Note in 2020
Lura Health develops a non-invasive continuous health monitoring platform that uses saliva as a diagnostic fluid. The company integrates micro-sensors into orthodontic devices such as retainers, aligners, and brackets to continuously measure saliva analytes and securely transmit data to a smartphone app, enabling users to monitor oral health metrics and potentially support broader chronic disease management. Target markets include heart disease, chronic kidney disease, diabetes, and tooth decay. Founded in 2017, the company is based in Cambridge, Massachusetts.

RxAll

Seed Round in 2020
RxAll, Inc. is a technology company that specializes in developing an artificial intelligence-driven platform for the authentication and distribution of pharmaceuticals, primarily in Africa. Founded in 2015 and headquartered in New Haven, Connecticut, the company utilizes a deep learning hyperspectral Internet of Things (IoT) platform that incorporates a molecular sensor device and a cloud database of spectral signatures. This innovative approach allows for non-destructive authentication of medications, including prescription and over-the-counter drugs, before they are dispensed. RxAll aims to combat the issue of counterfeit drugs by providing real-time information to pharmaceutical manufacturers about the authenticity of their products. Additionally, the platform facilitates access to authenticated medicines for patients and pharmacies, while also offering tele-pharmacy primary care services.

Zennea Technologies

Seed Round in 2020
Zennea Technologies is a medical device company based in Surrey, Canada, specializing in the development of therapeutic wearables aimed at reducing snoring and improving overall health through enhanced sleep quality. The company's flagship product, ZENS, is a comfortable and discreet sleep wearable that targets the root cause of snoring, thereby assisting individuals with chronic snoring and mild obstructive sleep apnea. Zennea conducts clinical trials to validate the efficacy of its device, which not only helps reduce snoring but also tracks sleep quality, providing valuable insights for users to make informed decisions about their health and sleep habits.

Intelligent Implants

Series A in 2019
Intelligent Implants is a bioelectronics company developing an implantable electrical stimulation platform that uses wireless devices to stimulate, steer, and monitor bone growth and tissue recovery. The company designs electrotherapeutic medical devices intended to treat diseases and accelerate healing in bone and other tissues. Its implants enable healthcare providers to control and monitor treatment, supporting decision making in patient care. By integrating data, engineering and medicine, Intelligent Implants aims to bring active, connected medical devices to clinical practice, improving outcomes for individuals with bone conditions and related injuries.

Babybe

Convertible Note in 2019
Babybe GmbH is a medical device company based in Stuttgart, Germany, founded in 2013 by Raphael P. M. Lang and Camilo Anabalon. The company specializes in products designed for premature infants and their mothers, notably the Babybe System, a bionic mattress that enhances the connection between them during incubation. This innovative device replicates the mother's heartbeat, breathing, and voice in real-time, providing multisensory stimulation that supports the infant's neurodevelopment and improves health outcomes. By facilitating a connection when direct contact is not possible, the Babybe System aims to help preterm babies recover more quickly, reduce healthcare costs for families, and enhance patient care within neonatal intensive care units. As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.

Cradlewise

Convertible Note in 2019
Cradlewise develops intelligent baby cribs that learn a baby's sleep patterns, mimicking a parent's soothing motion to help lull them back to sleep. Its smart cradles monitor infant health and activity, including breath rate, posture, and movement, aiming to enhance parental care and reduce the risk of sudden infant death syndrome.

kegg

Convertible Note in 2019
kegg is a fertility health tracking device from a San Francisco based company founded in 2017 that combines fertility tracking with pelvic floor exercises. The device analyzes changes in cervical fluids to detect the fertile window and ovulation up to seven days in advance, providing users with information to guide conception decisions. By collecting data from cervical fluids, it aims to support women’s health through improved diagnosis, monitoring, and planning related to fertility.

Sepsitron

Pre Seed Round in 2019
Sepsitron is a medical diagnostic technology company focused on the early detection of blood infections. Its innovative approach utilizes a combination of unique biomarkers, microfluidics, and advanced electronics to enable rapid identification of multiple pathogens—including viral, bacterial, parasitic, and fungal—using a single test. The device is designed for point-of-care applications, offering a significant advantage by delivering results 50 times faster and at one-tenth the cost of conventional methods. Importantly, Sepsitron's tests do not require any sample pre-processing and can analyze whole blood samples, allowing healthcare professionals to diagnose and initiate treatment for infections more efficiently.

Japet Medical

Convertible Note in 2019
Japet Medical is a French biomedical company specializing in the development of robotic medical devices. Their focus lies in creating efficient and user-friendly solutions designed to enhance treatment quality and improve patients' lives.

Feel Therapeutics

Seed Round in 2019
Feel Therapeutics is a digital health company specializing in precision medicine for mental health. It develops physiological and digital biomarkers using advanced computer science methods, leveraging wearable devices to collect and analyze biometric data.

RxAll

Pre Seed Round in 2019
RxAll, Inc. is a technology company that specializes in developing an artificial intelligence-driven platform for the authentication and distribution of pharmaceuticals, primarily in Africa. Founded in 2015 and headquartered in New Haven, Connecticut, the company utilizes a deep learning hyperspectral Internet of Things (IoT) platform that incorporates a molecular sensor device and a cloud database of spectral signatures. This innovative approach allows for non-destructive authentication of medications, including prescription and over-the-counter drugs, before they are dispensed. RxAll aims to combat the issue of counterfeit drugs by providing real-time information to pharmaceutical manufacturers about the authenticity of their products. Additionally, the platform facilitates access to authenticated medicines for patients and pharmacies, while also offering tele-pharmacy primary care services.

Seein Health

Venture Round in 2019
Seein Health is a company focused on developing products that support pregnancy and fertility. Its product range includes thermometers, menstrual test strips, and advanced physiological parameter monitoring equipment. These offerings are designed to ensure the health and safety of pregnant individuals, facilitating a proactive approach to fertility and pregnancy management. In addition to its core product line, Seein Health also provides innovative medical and hardware services, as well as overseas options for test-tube baby frozen eggs, further enhancing its commitment to reproductive health.

Intelligent Implants

Convertible Note in 2019
Intelligent Implants is a bioelectronics company developing an implantable electrical stimulation platform that uses wireless devices to stimulate, steer, and monitor bone growth and tissue recovery. The company designs electrotherapeutic medical devices intended to treat diseases and accelerate healing in bone and other tissues. Its implants enable healthcare providers to control and monitor treatment, supporting decision making in patient care. By integrating data, engineering and medicine, Intelligent Implants aims to bring active, connected medical devices to clinical practice, improving outcomes for individuals with bone conditions and related injuries.

Zennea Technologies

Convertible Note in 2019
Zennea Technologies is a medical device company based in Surrey, Canada, specializing in the development of therapeutic wearables aimed at reducing snoring and improving overall health through enhanced sleep quality. The company's flagship product, ZENS, is a comfortable and discreet sleep wearable that targets the root cause of snoring, thereby assisting individuals with chronic snoring and mild obstructive sleep apnea. Zennea conducts clinical trials to validate the efficacy of its device, which not only helps reduce snoring but also tracks sleep quality, providing valuable insights for users to make informed decisions about their health and sleep habits.

Kinexcs

Seed Round in 2019
Kinexcs is an AI-driven health technology company focused on improving mobility and quality of life for individuals with musculoskeletal conditions. It offers a digital therapy solution comprising KIMIA, the world's first continuous knee health monitor, and an AI-based digital therapist for convenient and cost-effective access to therapy.

ZiO Health

Seed Round in 2019
ZiO Health is a biotechnology company that develops pocket-sized devices featuring proprietary biosensor technology and machine learning algorithms. These devices enable real-time laboratory testing at the point-of-care, enhancing patient care by combining immediate results with individual patient profiles.

Cradlewise

Seed Round in 2019
Cradlewise develops intelligent baby cribs that learn a baby's sleep patterns, mimicking a parent's soothing motion to help lull them back to sleep. Its smart cradles monitor infant health and activity, including breath rate, posture, and movement, aiming to enhance parental care and reduce the risk of sudden infant death syndrome.

Bravrr

Pre Seed Round in 2019
Bravrr, LLC is a company based in Canon City, Colorado, founded in 2019, that specializes in the development of wearable diagnostic and therapeutic tools. Its flagship product, BruxRelief, is a smart biofeedback wearable designed to address bruxism disorder, which affects about one in three people yet remains largely undiagnosed. BruxRelief is an innovative headband equipped with advanced sensors and artificial intelligence to monitor and analyze users' clenching and grinding behaviors related to bruxism. By connecting to a smartphone app, it provides insights into nighttime bruxism activities and sleep patterns, enabling users to identify stress triggers and adopt measures to mitigate these harmful behaviors. Bravrr aims to revolutionize the bruxism market, which is valued at over $9 billion, by offering a user-friendly and effective alternative to traditional, complex diagnostic devices.

Strados Labs

Seed Round in 2019
Strados Labs, LLC is a medical technology company based in Philadelphia, Pennsylvania, specializing in respiratory health management through innovative sensor-based solutions. Founded in 2016, the company has developed a wearable device that provides real-time insights into breathing patterns, sounds, and speed. This device is equipped with clinical-grade biosensors and smart software, allowing for continuous monitoring of respiratory conditions such as asthma and chronic obstructive pulmonary disease. By connecting to a mobile application, Strados enables users and healthcare providers to access and analyze respiratory data, facilitating informed health decisions and remote patient monitoring.

Bold Diagnostics

Convertible Note in 2019
Bold Diagnostics is a medical device startup focused on developing an innovative diagnostic platform for blood pressure monitoring. The company has created a device that optimizes hypertension and pressure management by utilizing a novel parameter to derive noninvasive, cuffless blood pressure measurements. This pocket-sized device is designed for ambulatory use, allowing for impactful cardiovascular diagnostic measurements. By offering a more accurate, comfortable, and convenient alternative to traditional blood pressure monitoring methods, Bold Diagnostics aims to enhance the experience for both patients and healthcare providers.

Vitrix Health

Pre Seed Round in 2019
Vitrix Health, Inc. is a company that designs, develops, and manufactures innovative screening tools for the healthcare industry, specifically focusing on early-stage detection of oral diseases and cancers. Founded in 2018 and headquartered in Champaign, Illinois, Vitrix Health utilizes a combination of optics and machine learning on a mobile platform to enhance the effectiveness of oral health screenings conducted by primary care providers. This technology addresses the significant number of Americans who do not visit dentists regularly, thereby improving overall health outcomes and reducing costs. The company's oral cancer screening device is currently undergoing pilot testing in various prestigious institutions, including Mt. Sinai Hospital and the University of Chicago Medical School, in addition to international clinical trials in Bolivia and India. By empowering primary care providers to detect oral diseases, Vitrix Health aims to bridge disparities in oral health and ensure timely referrals for dental care.

Zennea Technologies

Convertible Note in 2019
Zennea Technologies is a medical device company based in Surrey, Canada, specializing in the development of therapeutic wearables aimed at reducing snoring and improving overall health through enhanced sleep quality. The company's flagship product, ZENS, is a comfortable and discreet sleep wearable that targets the root cause of snoring, thereby assisting individuals with chronic snoring and mild obstructive sleep apnea. Zennea conducts clinical trials to validate the efficacy of its device, which not only helps reduce snoring but also tracks sleep quality, providing valuable insights for users to make informed decisions about their health and sleep habits.

Lura Health

Seed Round in 2019
Lura Health develops a non-invasive continuous health monitoring platform that uses saliva as a diagnostic fluid. The company integrates micro-sensors into orthodontic devices such as retainers, aligners, and brackets to continuously measure saliva analytes and securely transmit data to a smartphone app, enabling users to monitor oral health metrics and potentially support broader chronic disease management. Target markets include heart disease, chronic kidney disease, diabetes, and tooth decay. Founded in 2017, the company is based in Cambridge, Massachusetts.

Babybe

Convertible Note in 2018
Babybe GmbH is a medical device company based in Stuttgart, Germany, founded in 2013 by Raphael P. M. Lang and Camilo Anabalon. The company specializes in products designed for premature infants and their mothers, notably the Babybe System, a bionic mattress that enhances the connection between them during incubation. This innovative device replicates the mother's heartbeat, breathing, and voice in real-time, providing multisensory stimulation that supports the infant's neurodevelopment and improves health outcomes. By facilitating a connection when direct contact is not possible, the Babybe System aims to help preterm babies recover more quickly, reduce healthcare costs for families, and enhance patient care within neonatal intensive care units. As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.

Kinexcs

Seed Round in 2018
Kinexcs is an AI-driven health technology company focused on improving mobility and quality of life for individuals with musculoskeletal conditions. It offers a digital therapy solution comprising KIMIA, the world's first continuous knee health monitor, and an AI-based digital therapist for convenient and cost-effective access to therapy.

Intelligent Implants

Seed Round in 2018
Intelligent Implants is a bioelectronics company developing an implantable electrical stimulation platform that uses wireless devices to stimulate, steer, and monitor bone growth and tissue recovery. The company designs electrotherapeutic medical devices intended to treat diseases and accelerate healing in bone and other tissues. Its implants enable healthcare providers to control and monitor treatment, supporting decision making in patient care. By integrating data, engineering and medicine, Intelligent Implants aims to bring active, connected medical devices to clinical practice, improving outcomes for individuals with bone conditions and related injuries.

Seein Health

Seed Round in 2018
Seein Health is a company focused on developing products that support pregnancy and fertility. Its product range includes thermometers, menstrual test strips, and advanced physiological parameter monitoring equipment. These offerings are designed to ensure the health and safety of pregnant individuals, facilitating a proactive approach to fertility and pregnancy management. In addition to its core product line, Seein Health also provides innovative medical and hardware services, as well as overseas options for test-tube baby frozen eggs, further enhancing its commitment to reproductive health.

Sana Health

Seed Round in 2018
Sana Health, Inc. is a digital health company based in Lafayette, Colorado, with an additional office in Mill Valley, California. Founded in 2015, the company specializes in developing bio-therapeutic devices designed to promote relaxation and alleviate pain and tension. Its flagship product, Sana, is a non-addictive mask and headphone combination that utilizes audiovisual stimulation to enhance the balance between the left and right sides of the brain, facilitating a deep meditative state. This device employs coordinated pulses of light and sound to guide users into relaxation, mimicking the benefits of long-term meditation practices. Sana Health is also engaged in multiple clinical studies, focusing on applications for conditions such as fibromyalgia and neuropathic pain, as well as trials related to anxiety and PTSD. The company offers its products for sale online and provides a mobile application accessible via major app platforms.

Babybe

Series A in 2018
Babybe GmbH is a medical device company based in Stuttgart, Germany, founded in 2013 by Raphael P. M. Lang and Camilo Anabalon. The company specializes in products designed for premature infants and their mothers, notably the Babybe System, a bionic mattress that enhances the connection between them during incubation. This innovative device replicates the mother's heartbeat, breathing, and voice in real-time, providing multisensory stimulation that supports the infant's neurodevelopment and improves health outcomes. By facilitating a connection when direct contact is not possible, the Babybe System aims to help preterm babies recover more quickly, reduce healthcare costs for families, and enhance patient care within neonatal intensive care units. As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.

kegg

Convertible Note in 2018
kegg is a fertility health tracking device from a San Francisco based company founded in 2017 that combines fertility tracking with pelvic floor exercises. The device analyzes changes in cervical fluids to detect the fertile window and ovulation up to seven days in advance, providing users with information to guide conception decisions. By collecting data from cervical fluids, it aims to support women’s health through improved diagnosis, monitoring, and planning related to fertility.

ZiO Health

Seed Round in 2018
ZiO Health is a biotechnology company that develops pocket-sized devices featuring proprietary biosensor technology and machine learning algorithms. These devices enable real-time laboratory testing at the point-of-care, enhancing patient care by combining immediate results with individual patient profiles.

Bold Diagnostics

Seed Round in 2018
Bold Diagnostics is a medical device startup focused on developing an innovative diagnostic platform for blood pressure monitoring. The company has created a device that optimizes hypertension and pressure management by utilizing a novel parameter to derive noninvasive, cuffless blood pressure measurements. This pocket-sized device is designed for ambulatory use, allowing for impactful cardiovascular diagnostic measurements. By offering a more accurate, comfortable, and convenient alternative to traditional blood pressure monitoring methods, Bold Diagnostics aims to enhance the experience for both patients and healthcare providers.

Bitome

Convertible Note in 2018
Bitome is a Boston-based connected medical device company focused on developing innovative monitoring solutions. Founded two years ago, it has created a noninvasive tool for assessing hydration status, which has significant applications in various fields, including dialysis, diabetes management, sports performance, and maternal/fetal health. The company's initial application targets patients with congestive heart failure (CHF), allowing for precise monitoring of volume status—an important yet challenging biometric to measure that is closely linked to patient outcomes. Bitome aims to revolutionize hydration monitoring in a manner comparable to the impact glucose monitoring has had on diabetes care.

Zennea Technologies

Pre Seed Round in 2018
Zennea Technologies is a medical device company based in Surrey, Canada, specializing in the development of therapeutic wearables aimed at reducing snoring and improving overall health through enhanced sleep quality. The company's flagship product, ZENS, is a comfortable and discreet sleep wearable that targets the root cause of snoring, thereby assisting individuals with chronic snoring and mild obstructive sleep apnea. Zennea conducts clinical trials to validate the efficacy of its device, which not only helps reduce snoring but also tracks sleep quality, providing valuable insights for users to make informed decisions about their health and sleep habits.

Criam

Convertible Note in 2018
Criam is a Portuguese biotechnology company based in Braga that develops portable diagnostic technology for blood typing and infectious disease detection. Its stand-alone platform does not require electricity or laboratory infrastructure, enabling rapid testing at the point of care. A single reader can perform multiple tests using cartridges and computer vision algorithms to detect a broad range of diseases, including HIV, with real-time data to support clinical decisions. The system leverages lab-on-a-chip concepts and biomarker detection algorithms to deliver fast, user-friendly, and cost-effective diagnostics in diverse settings, including remote environments and emergency care.

Pillsy

Seed Round in 2017
Pillsy is an enterprise-grade platform for remote patient support and rapid development of connected medication experiences. It is a new smart pill bottle and app that uses behavioral science to support healthy habits around vitamins and medications. It also securely share the pill-taking information with loved ones and to help monitor people. Pillsy was founded in 2015 and is headquartered in Seattle, Washington.

Babybe

Convertible Note in 2017
Babybe GmbH is a medical device company based in Stuttgart, Germany, founded in 2013 by Raphael P. M. Lang and Camilo Anabalon. The company specializes in products designed for premature infants and their mothers, notably the Babybe System, a bionic mattress that enhances the connection between them during incubation. This innovative device replicates the mother's heartbeat, breathing, and voice in real-time, providing multisensory stimulation that supports the infant's neurodevelopment and improves health outcomes. By facilitating a connection when direct contact is not possible, the Babybe System aims to help preterm babies recover more quickly, reduce healthcare costs for families, and enhance patient care within neonatal intensive care units. As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.

kegg

Seed Round in 2017
kegg is a fertility health tracking device from a San Francisco based company founded in 2017 that combines fertility tracking with pelvic floor exercises. The device analyzes changes in cervical fluids to detect the fertile window and ovulation up to seven days in advance, providing users with information to guide conception decisions. By collecting data from cervical fluids, it aims to support women’s health through improved diagnosis, monitoring, and planning related to fertility.

Fuller Vision

Seed Round in 2017
Fuller Vision develops autofocusing glasses that employ AI-eye tracking, miniaturized cameras and sensors, and dynamic lenses. These glasses mimic the natural focusing ability of young eyes, helping individuals with advanced presbyopia maintain a full range of focusing power.

AptaCam

Pre Seed Round in 2017
AptaCam is a biotechnology company based in Shenzhen, China, founded in 2014. The company specializes in developing biosensors for the detection of human papillomavirus (HPV) and other infectious diseases. AptaCam is also focused on creating a software solution that enhances the functionality of its portable diagnostic devices, allowing for effective data analysis and collection when connected to a computer. In addition to its biosensor technology, AptaCam aims to be a leading producer of high-quality aptamers, which are short, single-stranded nucleic acid molecules with high affinity and specificity for targeted applications. The company's innovative approach is designed to advance molecular recognition and support a wide range of disciplines, including clinical diagnostics, drug discovery, environmental monitoring, and food safety.

Kinexcs

Pre Seed Round in 2017
Kinexcs is an AI-driven health technology company focused on improving mobility and quality of life for individuals with musculoskeletal conditions. It offers a digital therapy solution comprising KIMIA, the world's first continuous knee health monitor, and an AI-based digital therapist for convenient and cost-effective access to therapy.

Japet Medical

Seed Round in 2017
Japet Medical is a French biomedical company specializing in the development of robotic medical devices. Their focus lies in creating efficient and user-friendly solutions designed to enhance treatment quality and improve patients' lives.

ZiO Health

Convertible Note in 2017
ZiO Health is a biotechnology company that develops pocket-sized devices featuring proprietary biosensor technology and machine learning algorithms. These devices enable real-time laboratory testing at the point-of-care, enhancing patient care by combining immediate results with individual patient profiles.

Sana Health

Convertible Note in 2017
Sana Health, Inc. is a digital health company based in Lafayette, Colorado, with an additional office in Mill Valley, California. Founded in 2015, the company specializes in developing bio-therapeutic devices designed to promote relaxation and alleviate pain and tension. Its flagship product, Sana, is a non-addictive mask and headphone combination that utilizes audiovisual stimulation to enhance the balance between the left and right sides of the brain, facilitating a deep meditative state. This device employs coordinated pulses of light and sound to guide users into relaxation, mimicking the benefits of long-term meditation practices. Sana Health is also engaged in multiple clinical studies, focusing on applications for conditions such as fibromyalgia and neuropathic pain, as well as trials related to anxiety and PTSD. The company offers its products for sale online and provides a mobile application accessible via major app platforms.

ZiO Health

Seed Round in 2017
ZiO Health is a biotechnology company that develops pocket-sized devices featuring proprietary biosensor technology and machine learning algorithms. These devices enable real-time laboratory testing at the point-of-care, enhancing patient care by combining immediate results with individual patient profiles.

Intelligent Implants

Seed Round in 2017
Intelligent Implants is a bioelectronics company developing an implantable electrical stimulation platform that uses wireless devices to stimulate, steer, and monitor bone growth and tissue recovery. The company designs electrotherapeutic medical devices intended to treat diseases and accelerate healing in bone and other tissues. Its implants enable healthcare providers to control and monitor treatment, supporting decision making in patient care. By integrating data, engineering and medicine, Intelligent Implants aims to bring active, connected medical devices to clinical practice, improving outcomes for individuals with bone conditions and related injuries.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.